Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lacombe

Showing results (171-180 of 196) with videos related to

Pageof 20
Sort By:
Diagnostic and Interventional Imaging|January 5, 2013
FDG-PET in the evaluation of myeloma in 2012C Bodet-Milin, T Eugène, C Bailly, et al.
Annales De Dermatologie Et De Venereologie|June 3, 2020
[An original reconstruction technique for double upper white lip defect]R Prud'homme, M Lacombe, S Delauménie, et al.
Blood|June 1, 1983
Restoration of normal hematopoiesis by bone marrow ablation and allogeneic marrow transplantation in a case of Hodgkin's disease therapy-related preleukemiaM Gyger, C Perreault, J Boileau, et al.
Transplantation|June 1, 1986
Prophylactic use of OKT3 monoclonal antibody in cadaver kidney recipients. Utilization of OKT3 as the sole immunosuppressive agentP Vigeral, N Chkoff, L Chatenoud, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 9, 2011
Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in miceM M van Beuge, J Prakash, M Lacombe, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Sex specific emergence of trisomic <i>Dyrk1a</i>-related skeletal phenotypes in the development of a Down syndrome mouse modelJonathan M LaCombe, Kourtney Sloan, Jared R Thomas, et al.
Transplantation Proceedings|February 1, 1989
A randomized trial comparing the efficacy of OKT3 used to prevent or to treat rejectionH Kreis, N Chkoff, L Chatenoud, et al.
EJNMMI Physics|February 17, 2026
Clinical value of artificial intelligence in reducing PET image acquisition time: routine clinical validation using qualitative, quantitative, and radiomic analysis on a cohort of 282 patients undergoing [<sup>18</sup>F]FDG and [<sup>68</sup>Ga]Ga-PSMA-11 PET/CTA Dambrain, M Lacombe, P A Dufour, et al.
Transplantation|March 1, 1988
One-month prophylactic use of OKT3 in cadaver kidney transplant recipientsA Debure, N Chkoff, L Chatenoud, et al.
L'Union Medicale Du Canada|January 1, 1988
[Allogeneic bone marrow transplantation and myeloid leukemia in the chronic and accelerated stages]M Gyger, C Perreault, R Bélanger, et al.
Pageof 20

Showing results (171-180 of 196) with videos related to

Sort By:
Pageof 20
Diagnostic and Interventional Imaging|January 5, 2013
FDG-PET in the evaluation of myeloma in 2012C Bodet-Milin, T Eugène, C Bailly, et al.
Annales De Dermatologie Et De Venereologie|June 3, 2020
[An original reconstruction technique for double upper white lip defect]R Prud'homme, M Lacombe, S Delauménie, et al.
Blood|June 1, 1983
Restoration of normal hematopoiesis by bone marrow ablation and allogeneic marrow transplantation in a case of Hodgkin's disease therapy-related preleukemiaM Gyger, C Perreault, J Boileau, et al.
Transplantation|June 1, 1986
Prophylactic use of OKT3 monoclonal antibody in cadaver kidney recipients. Utilization of OKT3 as the sole immunosuppressive agentP Vigeral, N Chkoff, L Chatenoud, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 9, 2011
Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in miceM M van Beuge, J Prakash, M Lacombe, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Sex specific emergence of trisomic <i>Dyrk1a</i>-related skeletal phenotypes in the development of a Down syndrome mouse modelJonathan M LaCombe, Kourtney Sloan, Jared R Thomas, et al.
Transplantation Proceedings|February 1, 1989
A randomized trial comparing the efficacy of OKT3 used to prevent or to treat rejectionH Kreis, N Chkoff, L Chatenoud, et al.
EJNMMI Physics|February 17, 2026
Clinical value of artificial intelligence in reducing PET image acquisition time: routine clinical validation using qualitative, quantitative, and radiomic analysis on a cohort of 282 patients undergoing [<sup>18</sup>F]FDG and [<sup>68</sup>Ga]Ga-PSMA-11 PET/CTA Dambrain, M Lacombe, P A Dufour, et al.
Transplantation|March 1, 1988
One-month prophylactic use of OKT3 in cadaver kidney transplant recipientsA Debure, N Chkoff, L Chatenoud, et al.
L'Union Medicale Du Canada|January 1, 1988
[Allogeneic bone marrow transplantation and myeloid leukemia in the chronic and accelerated stages]M Gyger, C Perreault, R Bélanger, et al.
Pageof 20